SOPHiA GENETICS (SOPH) Depreciation & Amortization - Total (2023 - 2024)

SOPHiA GENETICS (SOPH) posted Depreciation & Amortization - Total of $1.1 million for Q4 2024, down 2.91% sequentially from $1.2 million in Q4 2023, and down 2.91% YoY from $1.2 million in Q1 2024.

SOPHiA GENETICS (SOPH) Depreciation & Amortization - Total (2023 - 2024) Analysis & Trends

SOPHiA GENETICS has reported Depreciation & Amortization - Total for 2 years, with the latest figure at $1.1 million in Q4 2024.

  • Quarterly Depreciation & Amortization - Total fell 2.91% year-over-year to $1.1 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $1.1 million (down 2.91% YoY) and the FY2024 annual result came in at $4.6 million, down 24.13% from the prior year.
  • Depreciation & Amortization - Total retreated to $1.1 million in Q4 2024 per SOPH's latest filing, from $1.2 million in the prior quarter.
  • Over five years, Depreciation & Amortization - Total peaked at $1.2 million in Q4 2023 and troughed at $1.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 SOPHiA GENETICS 553.79 Mn 446.12 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 1.14 Mn
Dec 31, 2023 1.17 Mn